Skip to content

Support

Glaukos is Committed to Patient Access

Glaukos Patient Services (GPS) provides a wide array of services to help remove treatment barriers for iDose TR patients so that you can focus on providing the very best healthcare possible for those with glaucoma. 

Hand and Money icon

Overcome complex insurance coverage and reimbursement challenges with coding and billing guidance for office staff 
Hand and Key Icon

Deliver patients access to insurance coverage resources 
Hand and Information Bubble icon

Provide appeal support and information on available programs
Hand and Heart icon

Offer resources for patient advocacy awareness 
Glaukos Patient Services logo

To learn more about GPS, ask your sales representative for an introduction to your Reimbursement Liaison. 

Helpful Resources 

Ringed flipbook with person illustrated on the front

J Code
Quick Reference Guide

Download

Billing &
Coding Guide

Download
Ringed flipbook with person illustrated on the front

Billing &
Coding Quick Guide

Download
Ringed flipbook with person illustrated on the front

Consent Form

Download
iDose YourDose For A Brighter World

We strive to transform vision by pioneering unique, dropless platforms that can meaningfully advance the standard of care and improve outcomes for all patients living with glaucoma, the second leading cause of blindness in the US and around the globe.1 

For every iDose TR sold, Glaukos pledges to make available an equal number of iDose TR units for qualifying charitable donation requests around the globe.* 

For more information, email:

iDoseyourDose@glaukos.com

*Recipients of Glaukos product donations must satisfy independent eligibility requirements.

Ready to hear more?

Contact a representative to request more info.

  1. Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004 Nov;82(11):887-8. 2004 Dec 14. PMID: 15640929; PMCID: PMC2623060.

Important Safety Information

Dosage And Administration

For ophthalmic intracameral administration. The intracameral administration should be carried out under standard aseptic conditions.

Contraindications

iDose TR is contraindicated in patients with active or suspected ocular or periocular infections, patients with corneal endothelial cell dystrophy (e.g., Fuch’s Dystrophy, corneal guttatae), patients with prior corneal transplantation, or endothelial cell transplants (e.g., Descemet’s Stripping Automated Endothelial Keratoplasty [DSAEK]), patients with hypersensitivity to travoprost or to any other components of the product.

Warnings And Precautions

iDose TR should be used with caution in patients with narrow angles or other angle abnormalities. Monitor patients routinely to confirm the location of the iDose TR at the site of administration. Increased pigmentation of the iris can occur. Iris pigmentation is likely to be permanent.

Adverse Reactions

In controlled studies, the most common ocular adverse reactions reported in 2% to 6% of patients were increases in intraocular pressure, iritis, dry eye, visual field defects, eye pain, ocular hyperaemia, and reduced visual acuity.

Indications And Usage

iDose TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Please see full Prescribing Information.

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also call Glaukos at 1-888-404-1644.

The information contained in this site is intended for US healthcare professionals only

YES, I AM A US HEALTHCARE PROFESSIONAL NO, I AM NOT A US HEALTHCARE PROFESSIONAL

Request More Info

"*" indicates required fields

By entering this information, you confirm that you are at least 18 years old and that you have read and accept the terms of our Privacy Policy. Glaukos will use the information you provide on this form to provide product updates and other promotional materials. Should you change your mind, you may unsubscribe using the link in the footer of any email you receive from us.

Stay Connected

Sign up to receive the latest information about iDose® TR!

"*" indicates required fields

Glaukos will use the information you provide on this form to get in touch with you.

By entering this information, you confirm that you are at least 18 years old and that you have read and accept the terms of our Privacy Policy. Glaukos will use the information you provide on this form to provide product updates and other promotional materials. Should you change your mind, you may unsubscribe using the link in the footer of any email you receive from us.

This field is for validation purposes and should be left unchanged.